Nanomicelle-Microsphere Composite as a Drug Carrier to Improve Lung-Targeting Specificity for Lung Cancer

Lung cancer is the second-most common cancer and has the highest mortality among all cancer types. Nanoparticle (NP) drug delivery systems have been used to improve the therapeutic effectiveness of lung cancer, but rapid clearance and poor targeting limit their clinical utility. Here, we developed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qianqian, Bao, Jianwei, Duan, Tijie, Hu, Minxing, He, Yuting, Wang, Junwei, Hu, Rongfeng, Tang, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955237/
https://www.ncbi.nlm.nih.gov/pubmed/35335884
http://dx.doi.org/10.3390/pharmaceutics14030510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955237/
https://www.ncbi.nlm.nih.gov/pubmed/35335884
http://dx.doi.org/10.3390/pharmaceutics14030510

Ejemplares similares